Sana Biotechnology
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -3,895 | -3,746 | ||
EBITDA | -45,173 | -57,469 | -46,396 | -103,729 |
EBIT | -50,866 | -61,526 | -50,291 | -107,475 |
Net Income | -49,069 | -59,924 | -50,291 | -107,475 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -47,597 | -55,912 | -71,597 | -81,477 |
Cash | 127,566 | 126,996 | 138,790 | 180,886 |
Basic Shares | 236,299 | 235,412 | 234,440 | 217,290 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -30,865 | -27,731 | -17,914 | |
EBITDA | -272,723 | -252,390 | -256,939 | -345,839 |
EBIT | -283,255 | -272,564 | -356,909 | |
Net Income | -266,759 | -283,255 | -266,388 | -344,182 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -74,575 | 134,899 | ||
Free Cash Flow | -256,583 | -273,614 | -310,926 | -280,916 |
Cash | 127,566 | 133,517 | 176,765 | 253,029 |
Basic Shares | 230,891 | 194,541 | 188,344 | 166,433 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.23 |
2024-09-30 | -$0.25 |
2024-06-30 | -$0.32 |
2024-03-31 | -$0.32 |
